Replies to post #10708 on CryoPort Inc (CYRX)

[hyperopia]

Thanks CYRXorbust. That’s about what I remember; another ~10M shares of common reserved for warrants/options.

Sorry, I should have been more clear especially regarding this sore subject. I only meant dilution coming from the warrants/options, NOT another capital raise. As of June 30, they had $13 million in cash, and working capital of $12.5 million. Warrant exercises brought in another $1.8M at the end of July, and ~$6M in August, so Cryoport is financially very solid (also debt-free) for the foreseeable future.

You have a good point that management could have timed the capital raise better and should have been better prepared. I read somewhere that NVS requested that Cryoport have a better financial position in preparation for the commercialization.

I think it may be too early to expect management to provide sales forecasts at this point, but it’s entirely reasonable to hold them accountable for their performance. In their defense, margins are improving (all-time high last quarter), and operating expenses as a percentage of revenues last quarter was at an all-time low.